Estrogen receptor signaling in the immune system B Chakraborty, J Byemerwa, T Krebs, F Lim, CY Chang, DP McDonnell Endocrine reviews 44 (1), 117-141, 2023 | 58 | 2023 |
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma B Chakraborty, J Byemerwa, J Shepherd, CN Haines, R Baldi, W Gong, ... The Journal of clinical investigation 131 (23), 2021 | 51 | 2021 |
Turning up the heat: Oncolytic virus MEM-288 induces anti-tumoral immune response in pre-clinical models of high grade serous ovarian cancer (190) P Peters, R Whitaker, F Lim, S Russell, J Pollara, E Bloom, K Strickland, ... Gynecologic Oncology 176, S77, 2023 | | 2023 |
Oncolytic Adenovirus Mem-288 Encoding Membrane-Stable Cd40l and Ifnβ Induces an Anti-Tumor Immune Response in High Grade Serous Ovarian Cancer P Peters, RS Whitaker, F Lim, S Russell, EA Bloom, J Pollara, ... Available at SSRN 4804344, 2022 | | 2022 |
Abstract B05: Assessing estrogen receptor signaling and function in dendritic cells within the tumor microenvironment F Lim, C Haines, CY Chang, D Mcdonnell Cancer Immunology Research 10 (12_Supplement), B05-B05, 2022 | | 2022 |
Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer S Russell, F Lim, PN Peters, SE Wardell, R Whitaker, CY Chang, ... Cancers 14 (17), 4219, 2022 | | 2022 |